Overall similarity and consistency assessment scores are not sufficiently accurate for predicting discrepancy between direct and indirect comparison estimates

Journal of Clinical Epidemiology

Volumn 66, Issue 2, 2013, Pages 184-191

  Xiong, Tengbin ^a,b   Parekh Bhurke, Sheetal ^a,c   Loke, Yoon K ^a   Abdelhamid, Asmaa ^a   Sutton, Alex J ^d   Eastwood, Alison J ^e   Holland, Richard ^a   Chen, Yen Fu ^f   Walsh, Tanya ^g   Glenny, Anne Marie ^g   Song, Fujian ^a  

^a UNIVERSITY OF EAST ANGLIA   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d UNIVERSITY OF LEICESTER   (United Kingdom)

^e UNIVERSITY OF YORK   (United Kingdom)

^f UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^g UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Evidence consistency; Indirect treatment comparison; Mixed treatment comparison; Multiple treatment meta analysis; Network meta analysis; Trial similarity

Indexed keywords

AZELAIC ACID; METRONIDAZOLE; PLACEBO;

CLINICAL ASSESSMENT TOOL; COCHRANE LIBRARY; DATA ANALYSIS; HUMAN; OUTCOME ASSESSMENT; PREDICTION; PRIORITY JOURNAL; REVIEW; SCORING SYSTEM; TREATMENT DURATION; TRIAL SIMILARITY AND EVIDENCE CONSISTENCY ASSESSMENT;

BIAS (EPIDEMIOLOGY); EVIDENCE-BASED MEDICINE; GUIDELINE ADHERENCE; HUMANS; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; QUALITY ASSURANCE, HEALTH CARE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84871333665     PISSN: 08954356     EISSN: 18785921     Source Type: Journal    
DOI: 10.1016/j.jclinepi.2012.06.022     Document Type: Review

References (27)

1. F. Song, Y.K. Loke, T. Walsh, A.M. Glenny, A.J. Eastwood, and D.G. Altman Methodological problems in the use of indirect comparisons for evaluating healthcare interventions: a survey of published systematic reviews BMJ 338 2009 b1147 doi:10.113/bmj.b1147
2. S. Donegan, P. Williamson, C. Gamble, and C. Tudur-Smith Indirect comparisons: a review of reporting and methodological quality PLoS One 5 11 2010 e11054
3. J.P. Higgins, and A. Whitehead Borrowing strength from external trials in a meta-analysis Stat Med 15 24 1996 2733 2749
4. H.C. Bucher, G.H. Guyatt, L.E. Griffith, and S.D. Walter The results of direct and indirect treatment comparisons in meta-analysis of randomized controlled trials J Clin Epidemiol 50 1997 683 691
5. G. Lu, and A.E. Ades Combination of direct and indirect evidence in mixed treatment comparisons Stat Med 23 20 2004 3105 3124
6. T. Lumley Network meta-analysis for indirect treatment comparisons Stat Med 21 16 2002 2313 2324
7. F. Song, I. Harvey, and R. Lilford Adjusted indirect comparison may be less biased than direct comparison for evaluating new pharmaceutical interventions J Clin Epidemiol 61 2008 455 463
8. R. Chou, R. Fu, L.H. Huffman, and P.T. Korthuis Initial highly-active antiretroviral therapy with a protease inhibitor versus a non-nucleoside reverse transcriptase inhibitor: discrepancies between direct and indirect meta-analyses Lancet 368 2006 1503 1515
9. T. Li, M.A. Puhan, S.S. Vedula, S. Singh, and K. Dickersin Network meta-analysis-highly attractive but more methodological research is needed BMC Med 9 2011 79
10. F. Song, T. Xiong, S. Parekh-Bhurke, Y.K. Loke, A.J. Sutton, and A.J. Eastwood Inconsistency between direct and indirect comparisons of competing interventions: meta-epidemiological study BMJ 343 2011 d4909
11. J.P. Jansen, R. Fleurence, B. Devine, R. Itzler, A. Barrett, and N. Hawkins Interpreting indirect treatment comparisons and network meta-analysis for health-care decision making: report of the ISPOR Task Force on Indirect Treatment Comparisons Good Research Practices: part 1 Value Health 14 4 2011 417 428
12. J.P. Jansen, C.H. Schmid, and G. Salanti Directed acyclic graphs can help understand bias in indirect and mixed treatment comparisons J Clin Epidemiol 65 2012 798 807
13. J.J. Deeks, J.P. Higgins, and D.G. Altman Chapter 9: Analysing data and undertaking meta-analyses J. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions 2008 John Wiley & Sons, Ltd. Chichester, UK
14. J.P. Higgins, and D.G. Altman Chapter 8: Assessing risk of bias in included studies J. Higgins, S. Green, Cochrane Handbook for Systematic Reviews of Interventions 2008 John Wiley & Sons Chichester, UK
15. J.M. Bland, and D.G. Altman Statistical methods for assessing agreement between two methods of clinical measurement Lancet 1 1986 307 310
16. F. Song, D.G. Altman, A.M. Glenny, and J.J. Deeks Validity of indirect comparison for estimating efficacy of competing interventions: empirical evidence from published meta-analyses BMJ 326 2003 472 475
17. E.J. van Zuuren, M.A. Graber, S. Hollis, M. Chaudhry, A.K. Gupta, and M. Gover Interventions for rosacea Cochrane Database Syst Rev 3 2005 CD003262
18. B.E. Elewski, A.B. Fleischer Jr., and D.M. Pariser A comparison of 15% azelaic acid gel and 0.75% metronidazole gel in the topical treatment of papulopustular rosacea: results of a randomized trial Arch Dermatol 139 2003 1444 1450
19. I. Chalmers, and R. Matthews What are the implications of optimism bias in clinical research? Lancet 367 2006 449 450
20. H.C. Kraemer, E. Frank, and D.J. Kupfer Moderators of treatment outcomes: clinical, research, and policy importance JAMA 296 2006 1286 1289
21. P.M. Rothwell Factors that can affect the external validity of randomised controlled trials PLoS Clin Trials 1 1 2006 e9
22. S. Dias, N.J. Welton, A.J. Sutton, D.M. Caldwell, G. Lu, and A.E. Ades NICE DSU Technical Support Document 4: inconsistency in network of evidence based on randomised controlled trials 2011 Decision Support Unit, ScHARR, University of Sheffield Sheffield, UK
23. M. Coory, and S. Jordan Frequency of treatment-effect modification affecting indirect comparisons: a systematic review Pharmacoeconomics 28 9 2010 723 732
24. D.M. Caldwell, A.E. Ades, and J.P. Higgins Simultaneous comparison of multiple treatments: combining direct and indirect evidence BMJ 331 2005 897 900
25. N.J. Cooper, A.J. Sutton, D. Morris, A.E. Ades, and N.J. Welton Addressing between-study heterogeneity and inconsistency in mixed treatment comparisons: application to stroke prevention treatments in individuals with non-rheumatic atrial fibrillation Stat Med 28 14 2009 1861 1881
26. R.M. Nixon, N. Bansback, and A. Brennan Using mixed treatment comparisons and meta-regression to perform indirect comparisons to estimate the efficacy of biologic treatments in rheumatoid arthritis Stat Med 26 6 2007 1237 1254
27. G. Salanti, V. Marinho, and J.P. Higgins A case study of multiple-treatments meta-analysis demonstrates that covariates should be considered J Clin Epidemiol 62 2009 857 864